James T. Rosenbaum
Highly rated in
Highly rated in
Check Dr. James T. Rosenbaum's experience treating your condition:
About Dr. James T. Rosenbaum

James Rosenbaum is a Rheumatologist and an Ophthalmologist in Portland, Oregon. Rosenbaum has been practicing medicine for over 47 years and is highly rated in 31 conditions, according to our data. His top areas of expertise are Uveitis, Sarcoidosis, Scleritis, Cataract Removal, and Corneal Transplant. He is licensed to treat patients in Oregon. Rosenbaum is currently accepting new patients.

His clinical research consists of co-authoring 266 peer reviewed articles and participating in 6 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. James T. Rosenbaum it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. James T. Rosenbaum accepts the following insurance:

  •  Ambetter
  •  PacificSource
  •  Regence
  •  Moda Health
  •  Prominence Health
  •  BridgeSpan
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
Other Locations
515 Sw Campus Dr, Portland, OR 97239
Background & Education
Graduate Institution
Yale University School Of Medicine, 1975
Ophthalmology in OR
Hospital Affiliations
Good Shepherd Medical Center
Samaritan Pacific Communities Hospital
Salem Hospital
Legacy Good Samaritan Medical Center
CHI Mercy Health Mercy Medical Center
Providence St Vincent Medical Center
Trinity Health Saint Marys - Grand Rapids
OHSU Hospital - Portland
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Terbinafine Treatment of Axial Spondyloarthropathy
The Use of Remicade (Infliximab) in the Management of Vision-threatening Uveitis That is Refractory to Other Modes of Systemic Immunosuppression
A PhaseI/II Prospective, Randomized, Dose-Ranging Pilot Study of Rituximab in the Treatment of Refractory Scleritis and Non-Infectious Orbital Inflammation
Uveitis Gene-Expression Profiling
View 3 Less Clinical Trials -

266 Total Publications


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors